“The pandemic is a long way from over, and it will not be over anywhere until it’s over everywhere”, Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO) told journalists once more, at the regular press briefing in Geneva.
Still under threat
Media briefing on #COVID19 with @DrTedros https://t.co/gP0oSSnH4C
— World Health Organization (WHO) (@WHO) May 17, 2021
Tedros pointed to “dramatic increases” in cases, hospitalizations and deaths, in places where the coronavirus had previously been contained and added that new variants, fragile health systems, relaxed public health measures – and shortages of oxygen, dexamethasone and vaccines – were compounding the problem.
“But there are solutions”, he said, urging people to adhere to physical distancing, continue to wear masks and avoid large gatherings. “Even where cases have dropped, genetic sequencing is critical so that variants can be tracked and measures are not eased prematurely”.
Urgent financial support needed
Although WHO has been responding to the surge in India and other flashpoints, immediate additional funding is required to sustain support in all countries experiencing new waves of cases.
The 2021 response plan is already underfunded, and the vast majority of it is “ring fenced” by donors for specific countries or activities, which is constraining WHO’s ability to provide “an adaptable and scalable response in emerging hotspots”, Tedros said.
Urgent and flexible funding would allow the UN health agency to scale up support for countries and the ACT Accelerator.
Set ambitious goals ‘collectively’
Meanwhile, the UN Children’s Fund (UNICEF) outlined a 190 million dose shortfall in the UN-backed COVAX vaccine initiative for equitable COVID inoculations.
While COVAX has delivered 65 million doses to 124 countries and economies to date, the WHO chief called on manufacturers to publicly commit to sharing their vaccines with COVAX by lifting contractual barriers “within days not months”.
He also pressed manufacturers to give the right of first refusal to COVAX on any additional doses and encouraged them to make deals with companies willing to use their facilities to produce COVID-19 vaccines.
“We need to collectively set ambitious goals to at least vaccinate the world’s adult population as quickly as possible”, Tedros underscored.
Road safety priorities
Although pandemic lockdowns and telecommuting has led to fewer car journeys and road crashes, the WHO chief pointed to a converse problem caused by drivers’ speeding. This has meant the number of deaths had not decreased proportionately.
Kicking off UN Road Safety Week, Tedros asked for national and local policy commitments “to deliver 30 kilometre per hour speed limits in urban areas and generate local support for low speed measures overall”.
Addressing the risk of road traffic deaths is also fundamental to achieve the Sustainable Development Goals (SDGs), specifically those affecting health security, sustainable cities and reducing inequalities among and within countries.
And policies that tackle the of impact road traffic, and create environments for safe, sustainable and inclusive transport options, also unlock action for protecting the climate and gender equality.
A paradigm shift in how streets are designed can make streets safe, accessible and equitable for all road users – delivering multiple benefits while accelerating action across interlinking SDGs, according to WHO.
Key facts on road traffic injuries
- Approximately 1.35 million people die each year because of road crashes.
- The 2030 Agenda for Sustainable Development has set an ambitious target of halving the global number of deaths and injuries from road traffic crashes by 2020.
- Road traffic crashes cost most countries three per cent of their gross domestic product.
- More than half of all road traffic deaths are among pedestrians, cyclists and motorcyclists.
- Some 93 per cent of global road fatalities occur in low- and middle-income countries.
- Road traffic injuries are the leading cause of death for children and young adults aged 5-29 years.